David Lawrence
2009
In 2009, David Lawrence earned a total compensation of $910.6K as Chief Financial Officer at Acorda Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Bonus | $105,733 |
|---|---|
| Option Awards | $329,325 |
| Salary | $262,317 |
| Stock Awards | $205,900 |
| Other | $7,350 |
| Total | $910,625 |
Lawrence received $329.3K in option awards, accounting for 36% of the total pay in 2009.
Lawrence also received $105.7K in bonus, $262.3K in salary, $205.9K in stock awards and $7.4K in other compensation.
Rankings
In 2009, David Lawrence's compensation ranked 4,770th out of 9,885 executives tracked by ExecPay. In other words, Lawrence earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,770 out of 9,885 | 52nd |
Division Manufacturing | 1,704 out of 3,690 | 54th |
Major group Chemicals And Allied Products | 341 out of 866 | 61st |
Industry group Drugs | 209 out of 638 | 67th |
Industry Biological Products, Except Diagnostic Substances | 38 out of 133 | 71st |
Source: SEC filing on April 26, 2012.
Lawrence's colleagues
We found four more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2009.